HARMONY reaches milestone capturing data from 45,000 patients with blood cancersMPE, MyelomaJune 25, 2019
Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosisAccess, AL amyloidosisJune 6, 2019